Insider Selling: PACS Group (NYSE:PACS) CEO Sells $1,785,779.05 in Stock

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 37,477 shares of the business’s stock in a transaction on Tuesday, October 20th. The stock was sold at an average price of $47.65, for a total transaction of $1,785,779.05. Following the transaction, the chief executive officer owned 54,277,423 shares in the company, valued at approximately $2,586,319,205.95. The trade was a 0.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

  • On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total transaction of $314,768.20.
  • On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total transaction of $77,063.40.
  • On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total value of $402,875.82.
  • On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total value of $5,201,354.45.
  • On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total value of $10,440.00.
  • On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.
  • On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total value of $1,550,162.75.
  • On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total value of $1,033,395.84.
  • On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total value of $1,107,470.52.
  • On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total value of $1,358,606.16.

PACS Group Stock Performance

Shares of PACS stock traded down $1.03 during trading on Wednesday, reaching $46.69. 648,381 shares of the company’s stock were exchanged, compared to its average volume of 892,400. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $49.49. The firm’s fifty day moving average price is $43.58 and its 200-day moving average price is $40.70. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $7.39 billion, a PE ratio of 27.14, a PEG ratio of 1.43 and a beta of -0.08.

PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. As a group, sell-side analysts anticipate that PACS Group, Inc. will post 2.13 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on PACS shares. Zacks Research lowered shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. UBS Group lifted their target price on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Royal Bank Of Canada lifted their target price on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, August 6th. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings raised shares of PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, PACS Group currently has a consensus rating of “Moderate Buy” and an average target price of $58.80.

Check Out Our Latest Analysis on PACS

Hedge Funds Weigh In On PACS Group

A number of large investors have recently made changes to their positions in PACS. Squarepoint Ops LLC lifted its holdings in PACS Group by 94.7% during the 2nd quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock worth $2,538,000 after purchasing an additional 28,945 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in PACS Group in the 2nd quarter valued at $1,893,000. Engineers Gate Manager LP acquired a new position in PACS Group in the 2nd quarter valued at $1,132,000. Smith Group Asset Management LLC acquired a new position in PACS Group in the 1st quarter valued at $771,000. Finally, Principal Financial Group Inc. bought a new position in PACS Group during the 1st quarter worth $3,171,000.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

See Also

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.